Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Emerald Health Therapeutics Inc > Emerald Health Therapeutics To Begin Trading On CSE April 27
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(433)
•••
Post by AwareInvestoron Apr 23, 2021 8:57am
158 Views
Post# 33054057

Emerald Health Therapeutics To Begin Trading On CSE April 27

Emerald Health Therapeutics To Begin Trading On CSE April 27
Emerald Health Therapeutics has finalized the date on which it is to delist from the TSX Venture. The move to delist from the exchange is being conducted by the company as it looks to certain unrevealed opportunities within the US cannabis market.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities